| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 MYO5A CDHR2 CDH23 CDHR5 CABYR FAT1 FAT2 HMCN2 RPTN PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCLO PCDHA6 CUBN MACF1 UNC13C PLCH1 PCDHGC3 CDH5 CDH12 CDH17 | 2.71e-07 | 749 | 207 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDHR2 OBSCN CDH23 SH3GLB2 CDHR5 ITGA2 ITGA2B PROM1 FASN VWF DOCK9 PPL ICAM5 TLN1 MACF1 SCRIB CDH5 CDH12 CDH17 | 1.63e-05 | 599 | 207 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | cadherin binding | OBSCN CDH23 SH3GLB2 PROM1 FASN DOCK9 PPL TLN1 MACF1 SCRIB CDH5 CDH12 CDH17 | 5.66e-05 | 339 | 207 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 1.07e-04 | 2 | 207 | 2 | GO:0102521 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 HMCN2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 4.99e-12 | 187 | 203 | 17 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 SLITRK2 HMCN2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 2.19e-09 | 313 | 203 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYP1B1 DCHS2 ERBB2 CDHR2 ABCA12 CDH23 CDHR5 ITGA2 ITGA2B ITPKB FAT1 FAT2 SLITRK2 HMCN2 PKHD1 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 AKNA AMBRA1 PCDHA6 ICAM5 TLN1 SCRIB PCDHGC3 CDH5 CDH12 CDH17 | 2.54e-07 | 1077 | 203 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | epithelial cell development | RAPGEF6 ARID4B ABCA12 FASN TFCP2L1 FAT1 PKHD1 COL27A1 JMJD1C AKAP9 SCRIB CDH5 | 1.53e-05 | 269 | 203 | 12 | GO:0002064 |
| GeneOntologyBiologicalProcess | epithelium development | RAPGEF6 ARID4B MYO5A CDHR2 ABCA12 CCNO CDH23 ITGA2 PROM1 FREM2 FASN TFCP2L1 FAT1 PKHD1 USH2A TCTN1 CCDC40 FAT4 FRAS1 IPO7 COL27A1 COMMD5 AIRE AMBRA1 JMJD1C PPL TGFBR3 AKAP9 PHACTR4 SCRIB CDH5 | 4.58e-05 | 1469 | 203 | 31 | GO:0060429 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | RAPGEF6 ARID4B CDHR2 ABCA12 CCNO CDH23 ITGA2 PROM1 FASN TFCP2L1 FAT1 PKHD1 USH2A FAT4 IPO7 COL27A1 COMMD5 JMJD1C PPL AKAP9 SCRIB CDH5 | 5.01e-05 | 870 | 203 | 22 | GO:0030855 |
| GeneOntologyBiologicalProcess | intermicrovillar adhesion | 9.64e-05 | 2 | 203 | 2 | GO:0090675 | |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 1.18e-04 | 49 | 203 | 5 | GO:0003382 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.07e-06 | 137 | 206 | 10 | GO:0019897 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | CDH23 TOLLIP KALRN APOE CUBN PPL AKAP9 KIAA1755 SCRIB CDH5 CDH12 CDH17 | 3.18e-06 | 230 | 206 | 12 | GO:0019898 |
| GeneOntologyCellularComponent | catenin complex | 2.65e-04 | 32 | 206 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | apical part of cell | ERBB2 PLB1 RAPGEF6 CDHR2 CDH23 CDHR5 PROM1 FAT1 PKHD1 USH2A MGAM FAT4 SI CUBN SCRIB OCLN | 2.71e-04 | 592 | 206 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | sperm end piece | 2.88e-04 | 3 | 206 | 2 | GO:0097229 | |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB2 PLB1 RAPGEF6 CDHR2 CDHR5 PROM1 FAT1 PKHD1 USH2A MGAM SI CUBN SCRIB OCLN | 3.55e-04 | 487 | 206 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.83e-04 | 223 | 206 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.56e-04 | 278 | 206 | 10 | GO:0098858 | |
| GeneOntologyCellularComponent | microvillus membrane | 5.20e-04 | 38 | 206 | 4 | GO:0031528 | |
| GeneOntologyCellularComponent | extrinsic component of external side of plasma membrane | 5.72e-04 | 4 | 206 | 2 | GO:0031232 | |
| GeneOntologyCellularComponent | EARP complex | 9.48e-04 | 5 | 206 | 2 | GO:1990745 | |
| GeneOntologyCellularComponent | postsynapse | ERBB2 MYO5A SH3GLB2 VPS52 SLITRK2 RNF216 PCDH10 KIF17 DAGLA CHRNA6 KALRN PCLO LAMA2 DGKZ KPTN AKAP9 SLC18A2 DROSHA ICAM5 MACF1 SCRIB | 1.15e-03 | 1018 | 206 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | ciliary transition zone | 1.24e-03 | 81 | 206 | 5 | GO:0035869 | |
| GeneOntologyCellularComponent | basement membrane | 1.33e-03 | 122 | 206 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.41e-03 | 6 | 206 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | cell leading edge | ERBB2 MYO5A FAT1 USH2A DAGLA APBB2 DGKZ KPTN TLN1 PHACTR4 MACF1 SCRIB OCLN | 1.44e-03 | 500 | 206 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.62e-03 | 86 | 206 | 5 | GO:0001673 | |
| MousePheno | cryptophthalmos | 1.90e-06 | 3 | 174 | 3 | MP:0005242 | |
| MousePheno | absent eyelids | 1.06e-05 | 12 | 174 | 4 | MP:0001341 | |
| Domain | Cadherin | DCHS2 CDHR2 CDH23 CDHR5 FREM1 FREM2 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 7.54e-16 | 118 | 205 | 18 | IPR002126 |
| Domain | CA | DCHS2 CDHR2 CDH23 CDHR5 FREM2 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 8.47e-15 | 115 | 205 | 17 | SM00112 |
| Domain | Cadherin_CS | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 5.99e-14 | 109 | 205 | 16 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 1.07e-13 | 113 | 205 | 16 | PS00232 |
| Domain | CADHERIN_2 | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 1.23e-13 | 114 | 205 | 16 | PS50268 |
| Domain | - | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 1.23e-13 | 114 | 205 | 16 | 2.60.40.60 |
| Domain | Cadherin-like | DCHS2 CDHR2 CDH23 CDHR5 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 1.63e-13 | 116 | 205 | 16 | IPR015919 |
| Domain | Cadherin | DCHS2 CDHR2 CDH23 FAT1 FAT2 PCDH10 FAT4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHA6 PCDHGC3 CDH5 CDH12 CDH17 | 1.70e-12 | 113 | 205 | 15 | PF00028 |
| Domain | LAM_G_DOMAIN | 3.35e-06 | 38 | 205 | 6 | PS50025 | |
| Domain | Laminin_G | 4.09e-05 | 58 | 205 | 6 | IPR001791 | |
| Domain | Cadherin_tail | 4.97e-05 | 37 | 205 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 4.97e-05 | 37 | 205 | 5 | IPR031904 | |
| Domain | Laminin_G_2 | 7.30e-05 | 40 | 205 | 5 | PF02210 | |
| Domain | Cadherin_2 | 7.83e-05 | 65 | 205 | 6 | PF08266 | |
| Domain | Cadherin_N | 7.83e-05 | 65 | 205 | 6 | IPR013164 | |
| Domain | Cadherin_C | 9.28e-05 | 42 | 205 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 9.28e-05 | 42 | 205 | 5 | PF16492 | |
| Domain | Calx_beta | 1.04e-04 | 9 | 205 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.04e-04 | 9 | 205 | 3 | PF03160 | |
| Domain | LamG | 1.16e-04 | 44 | 205 | 5 | SM00282 | |
| Domain | Sec16_CCD | 1.20e-04 | 2 | 205 | 2 | IPR024340 | |
| Domain | Sec16 | 1.20e-04 | 2 | 205 | 2 | IPR024880 | |
| Domain | Sec16 | 1.20e-04 | 2 | 205 | 2 | PF12932 | |
| Domain | tRNA_wybutosine-synth | 1.20e-04 | 2 | 205 | 2 | IPR013917 | |
| Domain | Wyosine_form | 1.20e-04 | 2 | 205 | 2 | PF08608 | |
| Domain | Spectrin_repeat | 2.70e-04 | 29 | 205 | 4 | IPR002017 | |
| Domain | Sec16_C | 3.57e-04 | 3 | 205 | 2 | PF12931 | |
| Domain | ACE1_Sec16_Sec31 | 3.57e-04 | 3 | 205 | 2 | IPR024298 | |
| Domain | - | 6.28e-04 | 95 | 205 | 6 | 2.60.120.200 | |
| Domain | Glyco_hydro_31_CS | 7.09e-04 | 4 | 205 | 2 | IPR030459 | |
| Domain | Gal_mutarotase_N | 7.09e-04 | 4 | 205 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 7.09e-04 | 4 | 205 | 2 | PF16863 | |
| Domain | Biotin_BS | 1.17e-03 | 5 | 205 | 2 | IPR001882 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 1.17e-03 | 5 | 205 | 2 | PS00707 | |
| Domain | Biotin_COase_C | 1.17e-03 | 5 | 205 | 2 | IPR005482 | |
| Domain | BC | 1.17e-03 | 5 | 205 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 1.17e-03 | 5 | 205 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 1.17e-03 | 5 | 205 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 1.17e-03 | 5 | 205 | 2 | IPR011764 | |
| Domain | BIOTIN | 1.17e-03 | 5 | 205 | 2 | PS00188 | |
| Domain | Glyco_hydro_31_AS | 1.75e-03 | 6 | 205 | 2 | IPR030458 | |
| Domain | GAR | 1.75e-03 | 6 | 205 | 2 | PS51460 | |
| Domain | CP2 | 1.75e-03 | 6 | 205 | 2 | PF04516 | |
| Domain | CP2 | 1.75e-03 | 6 | 205 | 2 | IPR007604 | |
| Domain | Rudment_hybrid_motif | 1.75e-03 | 6 | 205 | 2 | IPR011054 | |
| Domain | RIIa | 1.75e-03 | 6 | 205 | 2 | SM00394 | |
| Domain | GAS2 | 1.75e-03 | 6 | 205 | 2 | PF02187 | |
| Domain | - | 1.75e-03 | 6 | 205 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.75e-03 | 6 | 205 | 2 | IPR003108 | |
| Domain | GAS2 | 1.75e-03 | 6 | 205 | 2 | SM00243 | |
| Pubmed | MON2 MTA2 CAAP1 ERBB2 ARID4B ACTR5 ABCA12 TSPYL2 ZNF518A FAT1 VPS52 HMCN2 BRCA1 SEC16A ANKRD52 RAE1 ARHGAP23 VPS50 KIAA1549 AMBRA1 CHD9 TTC7A DROSHA TBK1 MACF1 WDFY3 MRGBP SCRIB KIF18B | 3.41e-11 | 1116 | 208 | 29 | 31753913 | |
| Pubmed | ZBTB38 OBSCN SH3GLB2 BIRC6 MYO18B RABGGTB VWF IPO7 KALRN DOCK9 LAMA2 CCDC141 JMJD1C AKAP9 DROSHA TBK1 TLN1 MACF1 | 1.46e-09 | 497 | 208 | 18 | 23414517 | |
| Pubmed | ACACB BIRC6 TASOR2 PTPN3 FAT1 VPS52 BRCA1 SEC16A PCDH10 GOLGB1 IGSF3 SMAP1 FAT4 APBB2 HUWE1 PPL SEC24C PHACTR4 CEP131 SCRIB OCLN PC | 2.02e-09 | 777 | 208 | 22 | 35844135 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 RAPGEF6 HDAC4 MATK ITPKB FSIP2 PTPN3 WWC2 SEC16A GOLGB1 EHBP1 ARHGEF5 LARP1B AKAP9 DCP1B PHACTR4 MACF1 CEP131 SCRIB PLCH1 PC SAMD4A AHNAK2 | 2.56e-09 | 861 | 208 | 23 | 36931259 |
| Pubmed | BIRC6 ZNF518A SEC16A DAGLA PRUNE2 DOCK9 TTC7A TLN1 HELZ2 MACF1 WDFY3 SCRIB | 1.30e-08 | 225 | 208 | 12 | 12168954 | |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 16059920 | ||
| Pubmed | ERBB2 RAPGEF6 ACACB ITGA2 SEC16A GOLGB1 EHBP1 APBB2 PHACTR4 LRRC1 MACF1 SCRIB OCLN PLCH1 SLC12A7 | 4.42e-08 | 421 | 208 | 15 | 36976175 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MTA2 ERBB2 RAPGEF6 OBSCN BIRC6 FASN FAT1 SEC16A IGSF3 FRAS1 KALRN DOCK9 AKNA AMBRA1 HUWE1 GAS2L1 TLN1 HELZ2 NPRL3 CEP131 WDFY3 PC AHNAK2 | 5.88e-08 | 1105 | 208 | 24 | 35748872 |
| Pubmed | RAPGEF6 NCAPG2 XAB2 FREM2 RNF216 FRAS1 ARHGAP23 ARHGEF5 AMBRA1 JMJD1C DROSHA TBK1 MARF1 SCRIB PLCH1 SLC12A7 PCDHGC3 RAVER1 | 8.86e-08 | 650 | 208 | 18 | 38777146 | |
| Pubmed | MTA2 MYO5A ITGA2 ITPKB FASN HECW2 SEC16A TOLLIP DNAH6 DAGLA SMAP1 VWF ARHGAP23 KALRN PCLO KIAA1549 DGKZ APOE GAS2L1 SEC24C ICAM5 TLN1 PRKAR2A MACF1 SCRIB PLCH1 PC | 1.43e-07 | 1431 | 208 | 27 | 37142655 | |
| Pubmed | MON2 MAP3K4 SEC16A PCDH10 KIF17 FRAS1 DOCK9 VPS8 AKAP9 SEC24C TLN1 GPCPD1 MACF1 SCRIB | 1.93e-07 | 407 | 208 | 14 | 12693553 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.62e-07 | 72 | 208 | 7 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.17e-07 | 74 | 208 | 7 | 10817752 | |
| Pubmed | 4.17e-07 | 77 | 208 | 7 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.43e-07 | 80 | 208 | 7 | 10716726 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OBSCN ZNF226 BIRC6 FREM2 SAMD9L HECW2 PKHD1 PCDH10 FAT4 PCDHGB3 PCLO HUWE1 ADO DROSHA TBK1 TLN1 SCRIB RBM41 | 5.44e-07 | 736 | 208 | 18 | 29676528 |
| Pubmed | The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia. | 8.40e-07 | 4 | 208 | 3 | 29618029 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 23221805 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 36495293 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 18563433 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CDHR2 CDHR5 PROM1 FASN FAT1 PKHD1 PGLS TOLLIP MNDA NAA16 VWF KALRN VPS50 HUWE1 APOE CUBN PPL TGFBR3 TLN1 SERPINB1 PRKAR2A | 9.23e-07 | 1016 | 208 | 21 | 19056867 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CAAP1 RAPGEF6 ARID4B MATK WWC2 PPIG FASN SEC16A SEC16B HUWE1 TFAP4 PPL SEC24C PHACTR4 HELZ2 SCRIB CDH17 RAVER1 | 1.12e-06 | 774 | 208 | 18 | 15302935 |
| Pubmed | RAPGEF6 ACACB BIRC6 FASN SEC16A ANKRD52 GOLGB1 EHBP1 HUWE1 JMJD1C TBK1 CEP131 PC | 1.64e-06 | 418 | 208 | 13 | 34709266 | |
| Pubmed | BIRC6 FAT2 SAMD9L PRUNE2 EHBP1 SEC16B ARHGAP23 COL27A1 ATP10A JMJD1C HELZ2 MACF1 PLCH1 NEURL4 | 1.88e-06 | 493 | 208 | 14 | 15368895 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | CDHR5 ITGA2 PROM1 PTPN3 FAT1 SLITRK2 NRK IGSF3 EHBP1 DOCK9 KIAA1549 PHACTR4 SCRIB OCLN SLC12A7 | 2.00e-06 | 569 | 208 | 15 | 30639242 |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 39056782 | ||
| Pubmed | Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. | 2.09e-06 | 5 | 208 | 3 | 18086863 | |
| Pubmed | Novel frem1-related mouse phenotypes and evidence of genetic interactions with gata4 and slit3. | 2.09e-06 | 5 | 208 | 3 | 23536828 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 17596926 | ||
| Pubmed | Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development. | 2.09e-06 | 5 | 208 | 3 | 17251066 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CDH23 PPIG FAT1 SAMD9L HMCN2 MYO18B DNAH6 SEC16B SMCHD1 ATP10A JMJD1C MACF1 | 2.09e-06 | 361 | 208 | 12 | 26167880 |
| Pubmed | RAPGEF6 HDAC4 ACACB SH3GLB2 BIRC6 SEC16A ANKRD52 RAE1 KIAA1549 AKAP9 TBK1 CEP131 SAMD4A | 3.32e-06 | 446 | 208 | 13 | 24255178 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 3.42e-06 | 68 | 208 | 6 | 11230163 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 HDAC4 MYO5A TSPYL2 OBSCN TASOR2 ITPKB DAGLA GOLGB1 PRUNE2 EHBP1 APBB2 CHD9 MSH5 HUWE1 NAALADL2 ATP10A JMJD1C TFAP4 DNAH1 TBK1 LRRC1 MACF1 NRG3 RAVER1 | 3.49e-06 | 1489 | 208 | 25 | 28611215 |
| Pubmed | 3.56e-06 | 18 | 208 | 4 | 14730302 | ||
| Pubmed | 4.01e-06 | 152 | 208 | 8 | 34299191 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 24700879 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 17462874 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 20463225 | ||
| Pubmed | MON2 SAAL1 MYO5A BIRC6 PHKA1 PTPN3 WWC2 SEC16A ANKRD52 IPO7 KIAA1549 HUWE1 AKAP9 LRRC1 CEP131 SCRIB PC SLC12A7 NEURL4 RAVER1 | 5.68e-06 | 1049 | 208 | 20 | 27880917 | |
| Pubmed | ARID4B ACACB ORC6 NAP1L3 ITPKB ANKRD52 IGSF3 FAT4 IPO7 PRELP SERPINB1 WDFY3 CDH17 AHNAK2 RAVER1 | 7.91e-06 | 638 | 208 | 15 | 31182584 | |
| Pubmed | CALCOCO2 MTA2 MYO5A ORC6 BIRC6 NCAPG2 XAB2 FASN GOLGB1 IPO7 DOCK9 VPS50 AKNA HUWE1 APOE DCP1B HELZ2 MARF1 SERPINB1 PRKAR2A ITPRIP | 8.01e-06 | 1168 | 208 | 21 | 19946888 | |
| Pubmed | 8.03e-06 | 167 | 208 | 8 | 22159717 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ERBB2 SH3GLB2 FASN GOLGB1 EHBP1 ARHGAP23 DOCK9 PPL TTC7A TLN1 PHACTR4 MACF1 SCRIB OCLN | 8.90e-06 | 565 | 208 | 14 | 25468996 |
| Pubmed | MTA2 CAAP1 XAB2 PPIG FASN GCLM SEC16A SEC16B IPO7 RAE1 SMCHD1 LARP1B TFCP2 AKAP9 SEC24C DROSHA TBK1 TLN1 HELZ2 MARF1 CEP131 MRGBP PC | 8.93e-06 | 1371 | 208 | 23 | 36244648 | |
| Pubmed | MTA2 MYO5A BIRC6 XAB2 TASOR2 FASN SEC16A ANKRD52 IPO7 SMCHD1 HUWE1 SEC24C TLN1 HELZ2 MACF1 | 1.04e-05 | 653 | 208 | 15 | 22586326 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 26517044 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAPGEF6 HDAC4 ACACB TSPYL2 TASOR2 PRR14 PRUNE2 IPO7 ARHGEF5 CCDC141 TLN1 NEURL4 | 1.23e-05 | 430 | 208 | 12 | 35044719 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 SH3GLB2 RMI1 SEC16A ANKRD52 GOLGB1 RAE1 VPS50 HUWE1 ADO DROSHA TBK1 MACF1 CEP131 | 1.39e-05 | 588 | 208 | 14 | 38580884 |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 2.45e-05 | 10 | 208 | 3 | 15345741 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.60e-05 | 256 | 208 | 9 | 33397691 | |
| Pubmed | 2.63e-05 | 29 | 208 | 4 | 22613833 | ||
| Pubmed | ERBB2 FASN GCLM SEC16A GOLGB1 EHBP1 IPO7 JMJD1C SEC24C TLN1 PHACTR4 MACF1 SCRIB OCLN PLCH1 | 2.66e-05 | 708 | 208 | 15 | 39231216 | |
| Pubmed | MTA2 RAPGEF6 FASN SEC16A SMCHD1 HUWE1 APOE JMJD1C ICAM5 TLN1 PHACTR4 SCRIB PC | 2.99e-05 | 549 | 208 | 13 | 38280479 | |
| Pubmed | ZMYND19 SAAL1 RAPGEF6 OBSCN WWC2 KCNJ8 SEC16A TOLLIP GOLGB1 DOCK9 DGKZ MSH5 HUWE1 CUBN SEC24C TYW1B ITPRIP MACF1 TYW1 | 3.12e-05 | 1084 | 208 | 19 | 11544199 | |
| Pubmed | 3.22e-05 | 263 | 208 | 9 | 34702444 | ||
| Pubmed | DCHS2 ZBTB38 MYO5A TSPYL2 NAP1L3 SH3GLB2 XAB2 TOLLIP RNF216 VWF KALRN APBB2 AIRE CHD9 HUWE1 APOE DROSHA MACF1 WDFY3 SCRIB PC | 3.28e-05 | 1285 | 208 | 21 | 35914814 | |
| Pubmed | 3.36e-05 | 11 | 208 | 3 | 26114487 | ||
| Pubmed | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. | 3.36e-05 | 11 | 208 | 3 | 37352355 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12122014 | ||
| Pubmed | 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. | 3.56e-05 | 2 | 208 | 2 | 17452776 | |
| Pubmed | HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. | 3.56e-05 | 2 | 208 | 2 | 24342616 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 26107737 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12702516 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27714708 | ||
| Pubmed | HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. | 3.56e-05 | 2 | 208 | 2 | 24472556 | |
| Pubmed | Modulation of CP2 family transcriptional activity by CRTR-1 and sumoylation. | 3.56e-05 | 2 | 208 | 2 | 20661472 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 11728949 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27301358 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 29053796 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17240369 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 16162496 | ||
| Pubmed | Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies. | 3.56e-05 | 2 | 208 | 2 | 18084279 | |
| Pubmed | A homozygous mutation p.Arg2167Trp in FREM2 causes isolated cryptophthalmos. | 3.56e-05 | 2 | 208 | 2 | 29688405 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 21868708 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 10984423 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27480812 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27720815 | ||
| Pubmed | Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy. | 3.56e-05 | 2 | 208 | 2 | 28396568 | |
| Pubmed | FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration. | 3.56e-05 | 2 | 208 | 2 | 26936618 | |
| Pubmed | Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer. | 3.56e-05 | 2 | 208 | 2 | 25433947 | |
| Pubmed | Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoE-Deficient Mice. | 3.56e-05 | 2 | 208 | 2 | 26731274 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 38165568 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 21900877 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 34871294 | ||
| Pubmed | The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/β-Catenin Signaling Pathway. | 3.56e-05 | 2 | 208 | 2 | 31513346 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 25674245 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22049795 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17360660 | ||
| Pubmed | Molecular study of 33 families with Fraser syndrome new data and mutation review. | 3.56e-05 | 2 | 208 | 2 | 18671281 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 16103235 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 15235125 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 32643034 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 18528705 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17360538 | ||
| Pubmed | A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant. | 3.56e-05 | 2 | 208 | 2 | 37491606 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 36968271 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 1737795 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17872456 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 23419663 | ||
| Interaction | PFN1 interactions | MON2 CALCOCO2 RAPGEF6 MYO5A BIRC6 PHKA1 PPIG FASN BRCA1 SEC16A TOLLIP GOLGB1 PCLO AKAP9 DCP1B PRKAR2A MACF1 CEP131 AHNAK2 | 1.29e-06 | 509 | 206 | 19 | int:PFN1 |
| Interaction | XAGE1A interactions | 3.54e-06 | 41 | 206 | 6 | int:XAGE1A | |
| Interaction | CEACAM8 interactions | 3.75e-06 | 119 | 206 | 9 | int:CEACAM8 | |
| Interaction | GOLGA1 interactions | MON2 RAPGEF6 BIRC6 VPS52 SEC16A ANKRD52 GOLGB1 MACF1 CEP131 AHNAK2 | 1.95e-05 | 183 | 206 | 10 | int:GOLGA1 |
| GeneFamily | Cadherin related | 1.82e-11 | 17 | 133 | 7 | 24 | |
| GeneFamily | Clustered protocadherins | 1.08e-04 | 64 | 133 | 5 | 20 | |
| GeneFamily | PDZ domain containing | 9.13e-04 | 152 | 133 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.46e-03 | 8 | 133 | 2 | 939 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.23e-03 | 181 | 133 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.33e-03 | 36 | 133 | 3 | 823 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN | ACACB ABCA12 PROM1 FREM2 TFCP2L1 PXDNL COL27A1 TGFBR3 AHNAK2 | 1.16e-05 | 175 | 208 | 9 | M6750 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.16e-05 | 221 | 208 | 10 | M39222 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1 | 8.70e-19 | 184 | 208 | 18 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1 | 8.70e-19 | 184 | 208 | 18 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 OBSCN FREM1 FREM2 FAT1 SLITRK2 NRK PKHD1 USH2A PCDH10 MGAM FAT4 FRAS1 KALRN PCLO DNAH1 UNC13C PLCH1 | 8.70e-19 | 184 | 208 | 18 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 NALCN PKHD1 USH2A DNAH6 FRAS1 PCLO APOE CUBN DNAH1 UNC13C PLCH1 | 2.79e-11 | 169 | 208 | 12 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | ERBB2 FREM2 TFCP2L1 PKHD1 PCDH10 TRABD2A FRAS1 COL27A1 KIAA1549 TBK1 UNC13C | 1.26e-09 | 185 | 208 | 11 | 636505a3d96f75d951ab42bcf8af6ae07abc732d |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | MON2 ARID4B TSPYL2 BIRC6 TASOR2 GOLGB1 SMCHD1 HUWE1 JMJD1C GPCPD1 MACF1 | 1.49e-09 | 188 | 208 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | DCHS2 OBSCN SLITRK2 HECW2 KALRN DOCK9 ZFPM2 TGFBR3 NRG3 CDH5 | 2.31e-08 | 190 | 208 | 10 | 0a351609a72fd638c84b2435782e312ee6a33aac |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | MON2 RAPGEF6 ARID4B HDAC4 TSPYL2 SMCHD1 DOCK9 JMJD1C GPCPD1 MACF1 | 2.56e-08 | 192 | 208 | 10 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.11e-08 | 196 | 208 | 10 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.66e-07 | 178 | 208 | 9 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-07 | 183 | 208 | 9 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-07 | 183 | 208 | 9 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-07 | 183 | 208 | 9 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-07 | 183 | 208 | 9 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.20e-07 | 184 | 208 | 9 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-07 | 186 | 208 | 9 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-07 | 186 | 208 | 9 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-07 | 189 | 208 | 9 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-07 | 189 | 208 | 9 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-07 | 189 | 208 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-07 | 189 | 208 | 9 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.89e-07 | 190 | 208 | 9 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-07 | 191 | 208 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.02e-07 | 191 | 208 | 9 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.16e-07 | 192 | 208 | 9 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-07 | 193 | 208 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-07 | 194 | 208 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-07 | 194 | 208 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-07 | 195 | 208 | 9 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-07 | 196 | 208 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-07 | 196 | 208 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-07 | 197 | 208 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.45e-07 | 200 | 208 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.45e-07 | 200 | 208 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.45e-07 | 200 | 208 | 9 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.45e-07 | 200 | 208 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.45e-07 | 200 | 208 | 9 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-07 | 200 | 208 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.35e-07 | 153 | 208 | 8 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.67e-07 | 154 | 208 | 8 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.23e-06 | 167 | 208 | 8 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 171 | 208 | 8 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.47e-06 | 171 | 208 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 171 | 208 | 8 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.90e-06 | 177 | 208 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 179 | 208 | 8 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 180 | 208 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 181 | 208 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-06 | 181 | 208 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 181 | 208 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.34e-06 | 182 | 208 | 8 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-06 | 182 | 208 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-06 | 183 | 208 | 8 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.54e-06 | 184 | 208 | 8 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-06 | 185 | 208 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.86e-06 | 187 | 208 | 8 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.86e-06 | 187 | 208 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-06 | 188 | 208 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.98e-06 | 188 | 208 | 8 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.98e-06 | 188 | 208 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 2.98e-06 | 188 | 208 | 8 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.98e-06 | 188 | 208 | 8 | 986aaf31161ec3d1e6c76ee2dd17f44848a21f7e | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.10e-06 | 189 | 208 | 8 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 189 | 208 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 189 | 208 | 8 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.10e-06 | 189 | 208 | 8 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 3.22e-06 | 190 | 208 | 8 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.22e-06 | 190 | 208 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-06 | 190 | 208 | 8 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.22e-06 | 190 | 208 | 8 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 191 | 208 | 8 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.35e-06 | 191 | 208 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.35e-06 | 191 | 208 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 191 | 208 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-06 | 191 | 208 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 3.48e-06 | 192 | 208 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 3.48e-06 | 192 | 208 | 8 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.48e-06 | 192 | 208 | 8 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.48e-06 | 192 | 208 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.62e-06 | 193 | 208 | 8 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-06 | 193 | 208 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.62e-06 | 193 | 208 | 8 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 3.62e-06 | 193 | 208 | 8 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-06 | 193 | 208 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-06 | 193 | 208 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 3.62e-06 | 193 | 208 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 208 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 194 | 208 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-06 | 194 | 208 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 3.76e-06 | 194 | 208 | 8 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 208 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.90e-06 | 195 | 208 | 8 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | proximal-Endothelial-Vein|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.90e-06 | 195 | 208 | 8 | 0aebdd635a956dd2367883c1cf73d73ce9790635 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-06 | 195 | 208 | 8 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.90e-06 | 195 | 208 | 8 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | proximal-3-Endothelial-Vein|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.90e-06 | 195 | 208 | 8 | c81eb541c15b866f9b6ca6a5f1751c5f1243f4fb | |
| ToppCell | proximal-Endothelial-Vein-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.90e-06 | 195 | 208 | 8 | df00f94facc5d6107aac83cef3c64fefc7f8e562 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-06 | 195 | 208 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-06 | 195 | 208 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.96e-06 | 138 | 208 | 7 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | ARID4B RNF216 EHBP1 DOCK9 APBB2 AMBRA1 CHD9 JMJD1C LRRC1 WDFY3 PLCH1 | 5.93e-07 | 174 | 207 | 11 | 7530_DN |
| Drug | N-ethyl-N-nitrosourea | MTA2 ERBB2 ABCA12 CCNO ITGA2B MAP3K4 ITPKB KCNJ8 VWF SMCHD1 ZFPM2 NRG3 POLQ | 1.53e-06 | 275 | 207 | 13 | CID000012967 |
| Disease | venous thromboembolism, fibrinogen measurement | 4.17e-07 | 67 | 204 | 7 | EFO_0004286, EFO_0004623 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 1.30e-06 | 4 | 204 | 3 | DOID:0090001 (implicated_via_orthology) | |
| Disease | von Willebrand's disease 1 (is_implicated_in) | 1.30e-06 | 4 | 204 | 3 | DOID:0060573 (is_implicated_in) | |
| Disease | urate measurement, bone density | PLB1 ACTR5 FREM1 ITPKB FSIP2 A2ML1 SEC16A VWA3B USH2A FRAS1 NAALADL2 PPL DNAH1 HELZ2 KIAA1755 PRKAR2A CDH12 | 1.64e-06 | 619 | 204 | 17 | EFO_0003923, EFO_0004531 |
| Disease | Unilateral agenesis of kidney | 1.78e-05 | 8 | 204 | 3 | C0266294 | |
| Disease | platelet component distribution width | KREMEN1 ITGA2 ITGA2B ZPR1 CCDC40 PRUNE2 VWF KALRN DOCK9 APOE CUBN JMJD1C ZFPM2 ADO TLN1 MACF1 SLC12A7 | 2.20e-05 | 755 | 204 | 17 | EFO_0007984 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.44e-05 | 276 | 204 | 10 | EFO_0004612, EFO_0020943 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.47e-05 | 50 | 204 | 5 | EFO_0010732 | |
| Disease | von Willebrand's disease 2 (is_implicated_in) | 4.76e-05 | 2 | 204 | 2 | DOID:0060574 (is_implicated_in) | |
| Disease | Marles Greenberg Persaud syndrome | 4.76e-05 | 2 | 204 | 2 | C1855425 | |
| Disease | Malignant neoplasm of breast | CYP1B1 ERBB2 HDAC4 CYP24A1 OBSCN FASN BRCA1 MROH7 GOLGB1 EHBP1 VWF KALRN LAMA2 PANX2 CUBN AKAP9 ICAM5 MACF1 OCLN CDH5 | 6.09e-05 | 1074 | 204 | 20 | C0006142 |
| Disease | Disorder of eye | 1.21e-04 | 212 | 204 | 8 | C0015397 | |
| Disease | Proteinuria | 1.39e-04 | 15 | 204 | 3 | HP_0000093 | |
| Disease | Glanzmann's thrombasthenia (is_implicated_in) | 1.42e-04 | 3 | 204 | 2 | DOID:2219 (is_implicated_in) | |
| Disease | Cryptophthalmos syndrome | 1.42e-04 | 3 | 204 | 2 | C0265233 | |
| Disease | protocadherin beta-10 measurement | 1.42e-04 | 3 | 204 | 2 | EFO_0801974 | |
| Disease | FRASER SYNDROME 1 | 1.42e-04 | 3 | 204 | 2 | C4551480 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.66e-04 | 222 | 204 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.82e-04 | 225 | 204 | 8 | EFO_0008317, EFO_0020947 | |
| Disease | depressive symptom measurement | CAAP1 ACTR5 PKHD1 DAGLA EHBP1 VWF PCLO PCDHA6 MSH5 NAALADL2 PRKAR2A | 2.01e-04 | 426 | 204 | 11 | EFO_0007006 |
| Disease | mean platelet volume | ZBTB38 MYO5A CYP24A1 ITGA2 ITGA2B ZPR1 VWF PCDHGB7 PCDHGB5 KALRN PCDHGB3 CHD9 JMJD1C TFAP4 ZFPM2 ITPRIP SLC12A7 PCDHGC3 | 2.77e-04 | 1020 | 204 | 18 | EFO_0004584 |
| Disease | dihydrofolate reductase measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0801526 | |
| Disease | coronary artery disease (implicated_via_orthology) | 2.83e-04 | 4 | 204 | 2 | DOID:3393 (implicated_via_orthology) | |
| Disease | neutrophil-activating peptide 2 measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0020606 | |
| Disease | oleoyl-oleoyl-glycerol (18:1/18:1) [2] measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0800498 | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 2.83e-04 | 4 | 204 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.06e-04 | 243 | 204 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.68e-04 | 49 | 204 | 4 | EFO_0022256 | |
| Disease | cognitive inhibition measurement | 3.98e-04 | 50 | 204 | 4 | EFO_0007969 | |
| Disease | gestational age | 4.09e-04 | 138 | 204 | 6 | EFO_0005112 | |
| Disease | retinal drusen | 4.30e-04 | 51 | 204 | 4 | EFO_1001155 | |
| Disease | muscular disease (implicated_via_orthology) | 4.69e-04 | 5 | 204 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] measurement | 4.69e-04 | 5 | 204 | 2 | EFO_0800510 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.06e-04 | 200 | 204 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 5.21e-04 | 23 | 204 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.30e-04 | 264 | 204 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | triglyceride measurement, phospholipid measurement | 5.51e-04 | 146 | 204 | 6 | EFO_0004530, EFO_0004639 | |
| Disease | complex trait | 6.29e-04 | 271 | 204 | 8 | EFO_0010578 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.36e-04 | 150 | 204 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | FNAITP | 7.01e-04 | 6 | 204 | 2 | C3854603 | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 7.01e-04 | 6 | 204 | 2 | C3853779 | |
| Disease | gamma-enolase measurement | 7.01e-04 | 6 | 204 | 2 | EFO_0021845 | |
| Disease | Colorectal Neoplasms | 7.25e-04 | 277 | 204 | 8 | C0009404 | |
| Disease | glycerol measurement | 7.53e-04 | 26 | 204 | 3 | EFO_0010115 | |
| Disease | lung carcinoma (is_implicated_in) | 9.76e-04 | 7 | 204 | 2 | DOID:3905 (is_implicated_in) | |
| Disease | X-24870 measurement | 9.76e-04 | 7 | 204 | 2 | EFO_0022143 | |
| Disease | grapefruit juice consumption measurement | 9.76e-04 | 7 | 204 | 2 | EFO_0010094 | |
| Disease | vitamin k-dependent protein S measurement | 9.76e-04 | 7 | 204 | 2 | EFO_0020850 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.85e-04 | 224 | 204 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | carcinoma (implicated_via_orthology) | 1.02e-03 | 64 | 204 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | Ciliopathies | 1.02e-03 | 110 | 204 | 5 | C4277690 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.02e-03 | 110 | 204 | 5 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.02e-03 | 110 | 204 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.02e-03 | 110 | 204 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | 1,5 anhydroglucitol measurement | 1.04e-03 | 29 | 204 | 3 | EFO_0008009 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.12e-03 | 229 | 204 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | factor XI measurement, venous thromboembolism | 1.15e-03 | 30 | 204 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | immature platelet fraction | 1.20e-03 | 114 | 204 | 5 | EFO_0009187 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.21e-03 | 67 | 204 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | electrocardiography | OBSCN PROM1 PTPN3 HMCN2 MYO18B CCDC141 JMJD1C ZFPM2 NPRL3 KIAA1755 CDH17 | 1.23e-03 | 530 | 204 | 11 | EFO_0004327 |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.27e-03 | 31 | 204 | 3 | EFO_0022249 | |
| Disease | Colorectal Carcinoma | CALCOCO2 CYP1B1 ABCA12 OBSCN PROM1 CABYR FAT1 PKHD1 KALRN CUBN AKAP9 ICAM5 CDH5 | 1.28e-03 | 702 | 204 | 13 | C0009402 |
| Disease | Benign Neoplasm | 1.28e-03 | 68 | 204 | 4 | C0086692 | |
| Disease | Neoplasms | 1.28e-03 | 68 | 204 | 4 | C0027651 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.30e-03 | 8 | 204 | 2 | EFO_0008317, EFO_0008589, EFO_0008596 | |
| Disease | benign neoplasm (implicated_via_orthology) | 1.30e-03 | 8 | 204 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Dickkopf-related protein 4 measurement | 1.30e-03 | 8 | 204 | 2 | EFO_0008110 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.40e-03 | 118 | 204 | 5 | EFO_0010119 | |
| Disease | immature platelet measurement | 1.45e-03 | 119 | 204 | 5 | EFO_0803541 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.50e-03 | 71 | 204 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | platelet measurement | 1.65e-03 | 315 | 204 | 8 | EFO_0005036 | |
| Disease | DCN1-like protein 5 measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0801520 | |
| Disease | diacylglycerol 36:4 measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0020063 | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0020847 | |
| Disease | 22q11 partial monosomy syndrome | 1.66e-03 | 9 | 204 | 2 | C3266101 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.66e-03 | 34 | 204 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | puberty onset measurement | 1.80e-03 | 125 | 204 | 5 | EFO_0005677 | |
| Disease | Kartagener Syndrome | 1.81e-03 | 35 | 204 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.81e-03 | 35 | 204 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.81e-03 | 35 | 204 | 3 | C4317124 | |
| Disease | response to alcohol | 1.84e-03 | 75 | 204 | 4 | EFO_0005526 | |
| Disease | alkaline phosphatase measurement | CALCOCO2 ACACB CYP24A1 ITPKB PRR14 KIF17 GOLGB1 SEC16B LARP1B APOE JMJD1C TFAP4 PPL TTC7A MACF1 UNC13C | 1.94e-03 | 1015 | 204 | 16 | EFO_0004533 |
| Disease | Primary ciliary dyskinesia | 1.97e-03 | 36 | 204 | 3 | cv:C0008780 | |
| Disease | Malignant Neoplasms | 2.00e-03 | 128 | 204 | 5 | C0006826 | |
| Disease | 1,7-dimethylurate measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0021512 | |
| Disease | estrogen measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0011007 | |
| Disease | Asymmetric crying face association | 2.06e-03 | 10 | 204 | 2 | C0431406 | |
| Disease | CXCL5 measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0009422 | |
| Disease | C-X-C motif chemokine 5 measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0008058 | |
| Disease | quinone oxidoreductase-like protein 1 measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0021880 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0800333 | |
| Disease | 22q11 Deletion Syndrome | 2.06e-03 | 10 | 204 | 2 | C2936346 | |
| Disease | PR interval | ABCA12 OBSCN FREM2 FAT1 KALRN TFAP4 ZFPM2 KIAA1755 MACF1 SLC12A7 | 2.47e-03 | 495 | 204 | 10 | EFO_0004462 |
| Disease | degree of unsaturation measurement | 2.48e-03 | 39 | 204 | 3 | EFO_0022261 | |
| Disease | cytochrome p450 3a4 measurement | 2.51e-03 | 11 | 204 | 2 | EFO_0020303 | |
| Disease | coagulation factor XA measurement | 2.51e-03 | 11 | 204 | 2 | EFO_0020266 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 2.51e-03 | 11 | 204 | 2 | C1335302 | |
| Disease | kidney cancer (implicated_via_orthology) | 2.51e-03 | 11 | 204 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.51e-03 | 11 | 204 | 2 | EFO_0800332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EIEPFPEERENFLQQ | 301 | Q4LE39 | |
| PLQPEQLQVFETLEE | 391 | P04626 | |
| EQQLKVVPRFQPISE | 2091 | Q99996 | |
| RANVNLDVPLQVDFP | 566 | Q92870 | |
| EQAVETEPEPELRQQ | 21 | P02649 | |
| DVQTPLIIQPEQRNV | 806 | Q9NR09 | |
| PAQPVAQLDLQTFRD | 86 | P22674 | |
| LEDQEENPLPAALVQ | 216 | O95336 | |
| EPALNPLANRQQITE | 106 | Q9BYD9 | |
| QQFEPPLQPREREAV | 151 | Q96SZ5 | |
| IPIPDNRAEIISQVF | 586 | Q86UK0 | |
| FPVQQVEFISNPEVR | 1561 | Q12774 | |
| SQINPDLVREFPDVL | 56 | P48507 | |
| VEITLQDINDNPPVF | 1726 | Q6V0I7 | |
| ISIRPIPEENFLAAQ | 171 | Q9UNA3 | |
| VNRLVFQQDTLPNVP | 1281 | A8K2U0 | |
| PDTFRDQLQELCIPQ | 106 | Q9GZQ3 | |
| QLPEQIVIPFTDQVA | 311 | O75952 | |
| SPFDRNVPVNLELQE | 96 | Q9H9F9 | |
| PEDVQPSAQQLELLE | 326 | Q9H8G2 | |
| LQNAETQTEREVPEP | 1111 | Q9C0C7 | |
| EDPQERPPFQQIRLT | 786 | P16066 | |
| ITDQPPLVQAIFSRD | 6 | Q8NB46 | |
| QPLRIQAQDPEFSDL | 381 | Q9HBB8 | |
| INITDVDEPPIFQQP | 361 | P33151 | |
| DINDSRPEFLNPIQT | 2166 | Q9H251 | |
| LDRDVPANVLLTNPQ | 1141 | O60312 | |
| LQATVQEVQPRAEEP | 341 | O43918 | |
| PVSPCQNILRVIEEF | 671 | Q68CQ1 | |
| QLENQPSEFRRIESP | 196 | P78406 | |
| PSLTQQQFEELVRPF | 141 | Q8IY67 | |
| LTQPIEFVPEDEIQR | 271 | Q96IZ5 | |
| PDNPLTDRQIDQFLV | 181 | O94776 | |
| LLFPRENATVPENEE | 21 | Q8IWB1 | |
| VQELPLTSPVDDFRQ | 351 | Q16625 | |
| PQSLRPNSEEVDEVF | 126 | Q8WV74 | |
| RVRFFIPDPNTLQQE | 106 | P26045 | |
| AQIRILVIDANDNPP | 226 | Q9Y5F8 | |
| INDNPPLFPVEEQRV | 126 | Q9UN73 | |
| ESRFQVQTVLQFVPP | 1041 | Q9HCM3 | |
| RLAEQQPQPQFIPVD | 561 | Q86VD1 | |
| EDFPILFRQVQSEIP | 471 | O00763 | |
| QPNIFEILQERQPDL | 1091 | Q9P2P5 | |
| QQLEESRIPDQDTIP | 511 | P56975 | |
| VIVSVLDINDNPPVF | 3216 | Q14517 | |
| DQQLPVFQVTAPRLA | 1591 | Q86XX4 | |
| LDIPVDNPIESNNIF | 246 | Q15842 | |
| QFSLPVAEPALREQQ | 56 | P56524 | |
| VEPGQRQPSEQELLF | 576 | P56524 | |
| PIPRISQAEEEDQQL | 96 | Q9BX68 | |
| EAVQQLQPPEDGLFL | 131 | P42679 | |
| VQPVQPEEVSARDFL | 166 | Q8IV50 | |
| ITSPEFVDDRPQVVN | 181 | Q5JYT7 | |
| ADRNFTLQVQVPPVL | 3401 | Q8NDA2 | |
| ILVLQSAPVFQVEPQ | 4296 | Q8NDA2 | |
| VESVLNRVPQPEYRQ | 1111 | P46020 | |
| PVVNELERINCIPDQ | 91 | O43451 | |
| FVDPVLNQLQRPPQE | 996 | Q15652 | |
| RQFFPIVIIPTNDEQ | 1176 | Q5SZK8 | |
| QRPPLVQQRFLDVAN | 751 | Q8WW38 | |
| PIAPIIRNILNEIFQ | 1776 | Q5CZC0 | |
| DQVFPIAREEAPINL | 2841 | Q9Y6V0 | |
| VRVSIEDVNDNPPKF | 2056 | Q9NYQ8 | |
| VVNVSDINDNPPEFR | 2366 | Q9NYQ8 | |
| QLVDIREPETQPVCF | 86 | Q9UMF0 | |
| LENLRFPNNVEPVTN | 801 | O95373 | |
| QFEEQPVENLFPELT | 181 | Q9Y664 | |
| VPDPVLEESFQQLQR | 941 | O60437 | |
| LEEFRQTQQVPPNKI | 171 | Q6N069 | |
| EFRNPLAPAVQETQL | 376 | Q12980 | |
| FNITILPVDNQVPEA | 766 | Q5H8C1 | |
| LNPNFIQEVAPEFLV | 2461 | O60229 | |
| PQERPAVNQTVAEVI | 326 | Q96MU8 | |
| RIRVAPQQDDLDSPQ | 551 | P24043 | |
| IPPDNLSIQEFQRNE | 1506 | Q7Z3U7 | |
| TELRIQVTDANDNPP | 226 | Q9Y5G0 | |
| TQIRVIVADANDNPP | 226 | Q9Y5G1 | |
| TIVRVQVSDINDNPP | 441 | Q9UN70 | |
| FQVEIEVLDINDNPP | 106 | Q9P2E7 | |
| PPAIQEEVLAQQRAE | 3026 | Q7Z6Z7 | |
| LDVRQIPAAQEQPFI | 801 | P17301 | |
| QVVDERVLVFNPEEP | 31 | Q86Y91 | |
| QRPTPEELEQRNILQ | 591 | Q8IZ21 | |
| TEFLDPFQRVIQPEE | 21 | Q5VZY2 | |
| LSDNEIQRLPPEIAN | 66 | Q9BTT6 | |
| LIQRDQEPIPQNIDR | 6901 | Q9UPN3 | |
| RVLDVNDNPPVFSQD | 2436 | Q6V1P9 | |
| AENLEAQPQSTVRPE | 261 | Q13427 | |
| EQQEARAESPLPQVS | 7236 | Q5VST9 | |
| PEEVLQRVNVQPELV | 316 | P53611 | |
| PQVPQQTTVLDLRFN | 46 | A1KZ92 | |
| FVTEPQIIQERPLTN | 486 | P38398 | |
| LEEQNRQEPLIPVEQ | 236 | C9JJ37 | |
| LAAPPETRIQLQFED | 2251 | O60494 | |
| EQQTPLFQVISPQRI | 501 | Q8IZD4 | |
| TNLEPRFIEPQTANL | 3646 | Q9P2D7 | |
| NQFIRPVENVSDPVT | 46 | Q15825 | |
| LVDPNIFIQPITEER | 1906 | Q3L8U1 | |
| VVDQPDLDPQFVREF | 231 | Q9BYE9 | |
| LESIFNAPDIQRQLP | 1111 | Q9C0G6 | |
| EPVEFRCILEAQNVP | 296 | O75054 | |
| PEQPNIFQVEQLERL | 616 | Q9NPB8 | |
| NKFIAPSVPQQEERI | 1056 | Q6ZP82 | |
| NVQRINVRDVSPFPV | 1176 | Q9BZ29 | |
| IQSVLPENQVPRAED | 356 | Q07973 | |
| SIFRTPLQLDPQQEQ | 501 | Q99501 | |
| RITFTEPNIQNVPRD | 2241 | O75417 | |
| PREGDLPVFQDQIQQ | 236 | Q4G0X9 | |
| ELEDVPLQPQVQFLD | 606 | Q6UWU2 | |
| ITRVPQEFQTPEQAT | 426 | Q7Z591 | |
| IPFQFRPENEEDILV | 121 | Q13137 | |
| RTQDPQQLPIISVDN | 1826 | Q8IZC6 | |
| PNNLVNPVQELETER | 381 | Q8NDI1 | |
| QSADLIQFEERPQEP | 1646 | Q9Y4F3 | |
| QEILLRAQFEPNLVP | 956 | Q9Y4D2 | |
| VLRQQPPDLVEFAVE | 21 | P13861 | |
| QPQQTLATEPRENVI | 26 | P55289 | |
| PNPVRTVFREFEQLN | 251 | Q16678 | |
| PENLDFIEVNVSLPR | 261 | P30740 | |
| DQQPVPEQLRIQVSR | 636 | Q13574 | |
| LVDSFLQQDPAQPVV | 66 | Q9H9S5 | |
| PEARLVLEVQFQIDP | 461 | Q9BYK8 | |
| SAPRRQQEQQVPILE | 1101 | P49327 | |
| PSPVTVFEVQENERL | 341 | Q12864 | |
| PETRNQPLLDSIQDV | 516 | Q6T423 | |
| IPSPIQVIEDDRNNR | 326 | P53992 | |
| PRENSPFLNNVEVEQ | 46 | Q9Y666 | |
| DQPQEESEEQPVFRL | 231 | Q96ER3 | |
| QQPPEDRTQDVLAQD | 421 | Q9UPN4 | |
| QPLVPQLLVQVRIDF | 1166 | Q96JN8 | |
| ENLTPELPFEPNQEV | 526 | Q659C4 | |
| APQQILIATFDEPRT | 656 | Q96RD6 | |
| DPLPVVDQQQVLARL | 731 | Q9P2E2 | |
| DARRNVPQNDPVTVV | 201 | P41218 | |
| NRFTVLPNIDPEIDE | 391 | O43196 | |
| VPEIRQPIDNSFDIQ | 471 | Q9Y6R4 | |
| EEPESLRVNAQVFLP | 576 | Q7Z2Y5 | |
| IIQFFSPQPTEIRIQ | 386 | O75445 | |
| QLDREQFNPDVITFP | 756 | Q9NRR4 | |
| DLEPNEVRLEQQSVP | 831 | Q9HCS7 | |
| DFSNPSDIPDQVIRV | 741 | Q8TEU7 | |
| RVGVPFNIPLEFQDE | 836 | A6NHR9 | |
| NLPPREDIINVLQET | 201 | Q8WUY3 | |
| IPNNSNENIPRVTDV | 221 | Q9H9A7 | |
| LQRLPQAEPVEIVAF | 21 | Q71RC9 | |
| EPRFVEVLLQNNTPS | 286 | Q8IVG5 | |
| LQPPEALVERQGQFL | 336 | P27987 | |
| PERNFVLPEEIIQEV | 101 | Q9NV56 | |
| IDETPNFIIPAQRAE | 171 | Q9BWN1 | |
| PPVDAELDNVNNVLR | 336 | O43490 | |
| DQLPAFIQIDLQENP | 516 | Q9H156 | |
| EVLLQPNPSARVEEF | 61 | Q9NR46 | |
| EIEIQPRVVPNASFF | 426 | Q99457 | |
| PQTQQVDLDLSRPLF | 126 | Q9Y5N6 | |
| QLEEVPSALPRNLEQ | 161 | P51888 | |
| REITNQVVPQERQPE | 186 | Q9NWF9 | |
| QVVPQERQPEAELGR | 191 | Q9NWF9 | |
| EPVLDPQQIQAFDQL | 1356 | Q8N3P4 | |
| RVIVQSFPEEPSQVQ | 2186 | P08F94 | |
| NELPVQPQLVFLDEQ | 3756 | P08F94 | |
| VNVRINCIPEQFPTE | 71 | P14410 | |
| LSDNEIQRLPPEVAN | 66 | Q14160 | |
| QIFLPEPEQPSRLQD | 891 | P08514 | |
| EVPRVLVNLVDFLNP | 891 | Q6P1J6 | |
| QEEPQLSPENEARLP | 31 | Q9NZI6 | |
| FIPTVREVQCPEANI | 5406 | Q8IVF2 | |
| LIFNSFLPVNQPEEV | 521 | Q86XI2 | |
| ATIPRQDEVPQQTVA | 56 | Q9UBN6 | |
| REQPSDPQAEQELIN | 41 | Q96JG6 | |
| LEAPVTEPRFLEQLQ | 186 | Q8N1B4 | |
| LFRPISAEDEEQQPT | 31 | O75312 | |
| QLPTDPIEEQFPVLN | 131 | Q96E35 | |
| VFQPNQPLVDSIDLD | 841 | Q6AWC2 | |
| PPQQRPRLQEETEAA | 41 | Q9H2G4 | |
| VFPSNTQPFQRLLEE | 736 | Q8IZQ1 | |
| EIREDENQNIPEQPV | 946 | Q8NB66 | |
| NAPILIQDFETLPRE | 1646 | P04275 | |
| NLEFVQNQEVLPSEP | 461 | O15027 | |
| IDPRANPTQLNTVEF | 161 | Q12800 | |
| ETVRELLENPVQPIN | 1371 | Q9Y490 | |
| QPATENQRVPLIVAA | 911 | Q9P227 | |
| EIRDLYVNIQPVQEP | 221 | O00442 | |
| ELPQDFLRITPTQQQ | 16 | Q9H0E2 | |
| FTANPPQRVFELVDQ | 131 | Q2MV58 | |
| PQRVFELVDQINPSI | 136 | Q2MV58 | |
| FINATLPPQERITAQ | 276 | Q86V40 | |
| NLPENFRRPQTDQAV | 101 | Q8IYB5 | |
| SEFLPPEVNQLLQDV | 776 | Q6AHZ1 | |
| QALISPRETENNPFE | 86 | Q6ZUG5 | |
| ETLRPSVPEIFNNIQ | 1411 | Q4KWH8 | |
| TFQDDFVPQEIKPRQ | 116 | Q658L1 | |
| RQPPVANLINLTDED | 401 | Q96JE7 | |
| VAVVDQNPSQVRLPA | 1011 | Q8IUG5 | |
| PFKQDVSPIERNEQL | 51 | Q9NYT6 | |
| ARPLDQVLVIDSPNN | 301 | P0CG32 | |
| LERAQQLAPSDPQVI | 521 | Q9ULT0 | |
| VRPINAEPVFQAQEI | 1671 | Q5VWN6 | |
| EVNQERSPQPAAVLT | 291 | Q8NAP3 | |
| VTNAQFPAEIRNLEP | 511 | Q9NV66 | |
| DQPPETVIDQVKRFQ | 611 | Q502W6 | |
| QRPNDPETVETILNL | 46 | Q6XPR3 | |
| QLFVLQPSRVQPESQ | 266 | Q05940 | |
| ENIFQTQPLNPILED | 206 | Q9HAV5 | |
| IDENPELFQLRPAQN | 481 | P11498 | |
| LANIPLTPETQRDQE | 31 | Q01664 | |
| PEFQLPVTEPDINNR | 681 | Q9UPU9 | |
| DVPTLEPQERASVQF | 656 | O95932 | |
| PEPQQDEILQRLLFS | 51 | H3BTG2 | |
| QFPAEIRNLEPVTQL | 451 | Q6NUM6 | |
| ENPIFVVSREPLNTI | 376 | Q9UHD2 | |
| SIQLFPGLREPEEVQ | 431 | Q03167 | |
| PEELREPQQSFSEAQ | 3126 | Q14789 | |
| QQQELSRFLNPPSIE | 1601 | Q8IZF0 | |
| EVILQIANEPVLPFN | 636 | Q58DX5 | |
| AQNLQLPPEARIEAS | 1386 | Q9Y4I1 |